Search research articles
Contact Us
Filters
Showing results (191-200 of 267) with videos related to
Page
of 27
Sort By:
Haematologica
|
October 26, 2019
Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort
Robert O Opoka, Heather A Hume, Teresa S Latham, et al.
The New England Journal of Medicine
|
December 4, 2018
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
Léon Tshilolo, George Tomlinson, Thomas N Williams, et al.
Blood
|
August 31, 2011
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia
Russell E Ware, Jenny M Despotovic, Nicole A Mortier, et al.
Frontiers in Physiology
|
April 12, 2021
Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia
Alina Sadaf, Katie G Seu, Elizabeth Thaman, et al.
Blood
|
December 2, 2011
Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin
Jeffrey D Lebensburger, Thad Howard, Yunming Hu, et al.
American Journal of Hematology
|
July 18, 2013
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial
Ofelia Alvarez, Nancy A Yovetich, J Paul Scott, et al.
Trials
|
September 22, 2023
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease
Luke R Smart, Catherine I Segbefia, Teresa S Latham, et al.
JMIR Research Protocols
|
June 4, 2017
Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia
Neelum D Jeste, Luisanna M Sánchez, Gabriela S Urcuyo, et al.
Journal of Pediatric Hematology/Oncology
|
July 26, 2018
Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia
Lori E Crosby, Ashley Walton, Lisa M Shook, et al.
Blood
|
August 24, 2012
Impact of hydroxyurea on clinical events in the BABY HUG trial
Courtney D Thornburg, Beatrice A Files, Zhaoyu Luo, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 267) with videos related to
Sort By:
Page
of 27
Haematologica
|
October 26, 2019
Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort
Robert O Opoka, Heather A Hume, Teresa S Latham, et al.
The New England Journal of Medicine
|
December 4, 2018
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
Léon Tshilolo, George Tomlinson, Thomas N Williams, et al.
Blood
|
August 31, 2011
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia
Russell E Ware, Jenny M Despotovic, Nicole A Mortier, et al.
Frontiers in Physiology
|
April 12, 2021
Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia
Alina Sadaf, Katie G Seu, Elizabeth Thaman, et al.
Blood
|
December 2, 2011
Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin
Jeffrey D Lebensburger, Thad Howard, Yunming Hu, et al.
American Journal of Hematology
|
July 18, 2013
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial
Ofelia Alvarez, Nancy A Yovetich, J Paul Scott, et al.
Trials
|
September 22, 2023
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease
Luke R Smart, Catherine I Segbefia, Teresa S Latham, et al.
JMIR Research Protocols
|
June 4, 2017
Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia
Neelum D Jeste, Luisanna M Sánchez, Gabriela S Urcuyo, et al.
Journal of Pediatric Hematology/Oncology
|
July 26, 2018
Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia
Lori E Crosby, Ashley Walton, Lisa M Shook, et al.
Blood
|
August 24, 2012
Impact of hydroxyurea on clinical events in the BABY HUG trial
Courtney D Thornburg, Beatrice A Files, Zhaoyu Luo, et al.
Page
of 27